Cassava Sciences, Inc. $20.23
-
-
Kayla 1 year ago bullish
What is going on with SAVA it is trending up
-
stockmaster 2 years ago neutral
Share are trading lower today after the company reported biomarker data from an open-label study of simufilam – their investigational drug for the treatment of Alzheimer’s disease. Not sure why this would move it down… but I believe the stock has traded lower today due to unusual options activity.
Is this true?
-
TrendyToros
Start your discussions now!
-